Paradigm Biocapital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001855655 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value: $852M (100.0% shares, 0.0% debt)

Holdings (23)

INCY INCYTE CORP 8.0%
Value $68.5M Shares 852,830 Est. Cost $74.59 Unrealized +2.6%
BIIB BIOGEN INC 7.8%
Value $66.12M Shares 238,772 Est. Cost $237.08 Unrealized +19.1%
MIRATI THERAPEUTICS INC 6.7%
Value $57.45M Shares 1,267,970 Est. Cost $66.52 Unrealized
HORIZON THERAPEUTICS PUB L 6.4%
Value $54.35M Shares 477,585 Est. Cost $75.60 Unrealized
LEGN LEGEND BIOTECH CORP 6.2%
Value $52.66M Shares 1,054,870 Est. Cost $42.97 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 6.0%
Value $51.15M Shares 1,751,167 Est. Cost $18.66 Unrealized +23.5%
SNDX SYNDAX PHARMACEUTICALS INC 5.8%
Value $49.74M Shares 1,954,512 Est. Cost $20.69 Unrealized +12.8%
IMCR IMMUNOCORE HLDGS PLC 5.7%
Value $48.96M Shares 857,925 Est. Cost $36.82 Unrealized
ASND ASCENDIS PHARMA A/S 5.1%
Value $43.09M Shares 352,808 Est. Cost $117.62 Unrealized
VOR BIOPHARMA INC 5.0%
Value $42.84M Shares 6,442,825 Est. Cost $6.84 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 4.9%
Value $41.41M Shares 148,892 Est. Cost $200.45 Unrealized +25.9%
SEAGEN INC 4.3%
Value $36.79M Shares 286,288 Est. Cost $128.51 Unrealized
BCYC BICYCLE THERAPEUTICS PLC 4.3%
Value $36.51M Shares 1,233,280 Est. Cost $18.13 Unrealized
ARGX ARGENX SE 4.0%
Value $33.93M Shares 89,556 Est. Cost $378.46 Unrealized
AKERO THERAPEUTICS INC 3.9%
Value $33.13M Shares 604,544 Est. Cost $34.05 Unrealized
ACLX ARCELLX INC 3.2%
Value $27.33M Shares 882,101 Est. Cost $22.94 Unrealized 0.0%
KARUNA THERAPEUTICS INC 2.4%
Value $20.87M Shares 106,210 Est. Cost $196.50 Unrealized
ARVN ARVINAS INC 2.4%
Value $20.51M Shares 599,599 Est. Cost $57.23 Unrealized -26.5%
ALPINE IMMUNE SCIENCES INC 2.0%
Value $17.03M Shares 2,317,634 Est. Cost $7.74 Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 1.9%
Value $16.29M Shares 890,105 Est. Cost $19.24 Unrealized -8.4%
ZLAB ZAI LAB LTD 1.9%
Value $15.82M Shares 515,274 Est. Cost $30.70 Unrealized
POSEIDA THERAPEUTICS INC 1.5%
Value $12.9M Shares 2,434,816 Est. Cost $3.79 Unrealized
PRTA PROTHENA CORP PLC 0.5%
Value $4.519M Shares 75,000 Est. Cost $31.61 Unrealized +85.2%